index
  :: Home :: Contact :: Site Map
  Search:
index
Event Overview
Register
Speaker List
Detailed Agenda
Price/Info
Venue
Exhibitors and Sponsors
Poster Guidelines
Refer A Friend
Submit an Abstract
Other Conferences
Home
 
 
6th Annual Vaccines: All Things Considered
 

Register 2, the 3rd goes free!
Click here to send your team!

 

Dear Colleagues,

GTCbio is proud to present its 6th Annual Vaccines: “All Things Considered” conference to be held this year in Washington, D.C. on Nov 13-14, 2008. This conference is your one-stop destination to gain updates and exposure on all aspects of vaccine research, development, regulations, and policy.

The research and discovery of vaccines to fight globally prevalent diseases has been a major focus of the pharmaceutical industry’s biggest players for decades. The pharmaceutical world has been rocked recently by the pending expiration of the patents of several major block-buster drugs. How does this affect funding for vaccine research and development? What will be the path forward? How will the generic drug industry affect the vaccines market? These are just a few of the questions the Vaccines conference will answer.

There have also been many recent advancements in the discovery of novel vaccines that target not only the traditional infectious diseases, such as Malaria, Influenza, AIDS, Meningitis, etc, but also some innovative ideas to use vaccines to target non-infectious diseases such as cancer, allergies, and even smoking. This conference is the perfect forum to network with colleagues and gain valuable information on these new next generation vaccines.

To truly consider all things, GTCbio’s Vaccines conference will also bring together leading government officials, with representatives from the DHHS and the FDA, to provide you with a first-hand picture of the current US vaccines policy and regulations. Come and get updates on the pandemic and bio-defense policy as well as the National Vaccine Plan.

It is important for your organization to consider all of these factors before moving forward with Vaccine discovery and development. Don’t miss your opportunity to take all things into consideration and register for GTCbio’s 6th Annual Vaccines: “All Things Considered” conference.
 

Sincerely,

2008 Vaccines: All Things Considered Organizing Committee
 

Attend ONE additional Conference of your choice for only $400 more. Click here to sign up!
   
Attend ALL 2009 GTCbio Conferences for only $3000.
Click here to sign up!
   

 

 

Keynote Speakers




Norman Baylor
Director
Office of Vaccines
FDA

Natalie Garcon
Vice President and Head of Research
GSK Biologicals

 

Featured Speaker


Gregory Milman
Director, Office of Innovation
NIAID, NIH
 

 

 Media Partners
















 

 

 

 
index
  :: Conferences :: Exhibit and Sponsor :: Contact us :: Employment :: Request Info  
Copyright © 2006 Global Technology Community, LLC